Skip to Content
Merck
CN
  • Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy.

Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy.

American journal of kidney diseases : the official journal of the National Kidney Foundation (2013-12-10)
Napat Leeaphorn, Michael B Stokes, Patompong Ungprasert, William Lecates
ABSTRACT

Granulomatous interstitial nephritis (GIN) is a rare histologic disease. Various causes have been reported in the literature, including drugs, sarcoidosis, and infections. Other incidents have no discernible cause and are identified as idiopathic. We report a 68-year-old white man who presented with acute kidney injury and was given a diagnosis of idiopathic GIN. Mycophenolate mofetil treatment was elected because of steroid toxicity. He responded well to mycophenolate mofetil and has been in remission for more than 3 years. To our knowledge, this is the first report of successful treatment with mycophenolate mofetil of an adult patient with idiopathic GIN.

MATERIALS
Product Number
Brand
Product Description

Supelco
Mycophenolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Mycophenolate mofetil, European Pharmacopoeia (EP) Reference Standard
USP
Mycophenolate mofetil, United States Pharmacopeia (USP) Reference Standard
Mycophenolate mofetil for peak identification, European Pharmacopoeia (EP) Reference Standard